Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized treatment of patients with severe peripheral arterial disease (Leriche-Fontaine stage IIb) with iloprost
2006-001660-23Phase 4Completed
- Sponsor
- Fondazione FADOI
- Start
- Nov 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of iloprost in arteriosclerosis obliterans, sponsored by Fondazione FADOI. Primary endpoint: Pain-free walking distance on treadmill (PFWD). Started Nov 2009; status: completed.
02
Drugs
iloprost
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on 2006-001660-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001660-23.